T Slim X2 G6 Software Download Computer Software
SAN DIEGO--( Business WIRE )--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology visitor, today announced it is offering no-cost characteristic updates for t:slim X2 insulin pump customers in the U.s. through the cease of 2020.
- All software updates canonical by the U.Due south. Food and Drug Assistants (FDA) through the finish of 2020 will be offered for no toll
- Customers who buy a pump prior to December 31, 20201, including current customers, are eligible for software updates while in-warranty
- Software updates volition be offered through the Tandem Device Updater
"Our ability to provide our customers with remote feature updates exemplifies our Company'south mission to amend the lives of people with diabetes through relentless innovation and revolutionary client feel," said John Sheridan, president and CEO of Tandem Diabetes Care. "We see dandy value in our software updates, both big and modest. We believe like shooting fish in a barrel access to the latest t:slim X2 features as they are approved can help improve the lives of our customers, encourage more people to adopt pump therapy, and farther reinforce the benefit of our applied science with insurance providers."
Tandem is the just visitor offering a tool for remote software updates for its insulin pumps every bit new features are approved by the FDA. The Company previously demonstrated its marketplace-differentiating Tandem Device Updater in 2017 by successfully providing CGM integration to thousands of t:slim X2 customers for no cost post-obit FDA blessing of the t:slim X2 insulin pump with Dexcom G5 Mobile CGM integration, and again in 2018 following FDA approving of the t:slim X2 insulin pump with Basal-IQ technology.
Nearly the t:slim X2 Insulin Pump with Basal-IQ Technology
The simple-to-use t:slim X2 insulin pump with Basal-IQ predictive low glucose suspend engineering uses glucose values from an integrated Dexcom G6 continuous glucose monitor to predict and aid prevent lows. The t:slim X2 pump includes advanced features similar a big color touchscreen, rechargeable battery, Bluetooth® wireless technology, USB connectivity and watertight construction (IPX7)2. It is capable of remote software updates using a personal computer, offering the potential for users to access new features every bit they run into necessary regulatory requirements. The t:slim X2 Pump is up to 38 percent smaller than other insulin pumps and holds upward to 300 units of insulin.three
For additional product and safe information, visit www.tandemdiabetes.com/tslimX2info
or telephone call (877) 801-6901, Monday – Friday between 6am and 5pm Pacific Time
Free t:slim X2 Pump Demo on Your Mobile Device
Download Tandem'southward gratis t:simulator™ App to experience the touchscreen interface of the t:slim X2 pump with Basal-IQ technology directly on your mobile device. For more information and to download the app, visit http://world wide web.tandemdiabetes.com/tsimulator.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Intendance, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Visitor takes an innovative, user-centric arroyo to the design, evolution and commercialization of products for people with diabetes who utilize insulin. Tandem'south flagship production, the t:slim X2 insulin pump, is capable of remote software updates using a personal figurer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.
Tandem Diabetes Care and Basal-IQ are registered trademarks, and t:slim X2 and t:simulator are trademarks of Tandem Diabetes Care, Inc. Dexcom, Dexcom G5 and Dexcom G6 are registered trademarks of Dexcom, Inc. The Bluetooth word marking and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks past Tandem Diabetes Care, Inc. is under license. All other trademarks are the property of their respective owners.
Forward Looking Statement
This press release contains "forwards-looking statements" within the meaning of Department 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Human activity of 1934, equally amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. These forward-looking statements include statements regarding the Visitor's plans to make new t:slim X2 pump software updates approved by the FDA through 2020 available to in-warranty t:slim X2 pump users at no cost and the Visitor'southward belief that easier access to new pump features can help improve the lives of customers, encourage more people to adopt pump therapy, and further reinforce the benefit of the Company'southward engineering with insurance providers. The Company'due south actual results may differ materially from those indicated in these forrad-looking statements due to numerous risks and uncertainties, including the Company'southward power to complete the evolution and obtain required FDA approvals to offering future software updates using the Tandem Device Updater, the potential that competitive products or other technological developments and breakthroughs for the monitoring, treatment or prevention of diabetes may render the Company's products obsolete or less desirable or that the Visitor's products may non provide the expected benefits to users or insurance providers. Other risks and uncertainties are identified in the Company's most recent Annual Report on Form ten-K and Quarterly Report on Form x-Q, and other documents that the Company files with the Securities and Exchange Committee. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Tandem undertakes no obligation to update or review any forward-looking argument in this press release considering of new data, future events or other factors.
1 Additional feature updates are not currently available for the t:slim X2 pump with Basal-IQ technology and are subject area to hereafter FDA approvals. A prescription and additional training may be required to access sure future software updates. Offer only bachelor to customers who reside in the U.s.a., who are in warranty at the time they update their pump and who purchased a t:slim X2 insulin pump on or earlier December 31, 2020. Tandem may discontinue select software and features over time at its discretion. This is a express time offer and Tandem reserves the correct to discontinue this program at its discretion.
2 Tested to a depth of iii feet for xxx minutes
3 38 percentage smaller than MiniMed 630G and 670G and at least 28 per centum smaller than MiniMed 530G, Animas Vibe and Omnipod Organization. Data on file, Tandem Diabetes Care.
T Slim X2 G6 Software Download Computer Software
DOWNLOAD HERE
Source: https://www.businesswire.com/news/home/20190801005977/en/Tandem-Diabetes-Care-Announces-No-Cost-Software-Updates-for-tslim-X2-Insulin-Pump-Customers-in-the-United-States
Posted by: BFGGetthelatestWorldNews.blogspot.com
comment 0 comments
more_vert